Access to expensive cancer drugs limited in Korea

Korea has restricted access to very expensive cancer therapies in terms of fairness index and transparency, when compared to advanced countries, according to a report presented at the 2013 American Society of Clinical Oncology (ASCO) annual meeting.

When comparing access to high-cost cancer drugs in Korea and 10 advanced countries, the researchers found that Korea has no system for granting...